FTC Sues PBMs Over Insulin Prices, Citing a ‘Perverse System’
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said Friday in announcing an administrative complaint against firms that are divisions of CVS Health,
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of “engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while
FTC Takes Legal Action Against Three Largest PBMs Over High Insulin Prices
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed,
FTC sues big 3 PBMs for ‘artificially inflated’ insulin prices caused by ‘perverse’ rebating
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to pay more for insulin.
FTC targets 3 biggest PBMs over insulin rebates
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
Federal regulators sue three pharmacy benefit managers over high insulin prices
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
Feds sue pharmacy gatekeepers over high insulin costs
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming they are illegally maximizing profits by steering patients to high-cost insulin products.
FTC Sues CVS Health, Cigna And United Health Group For Inflating Insulin Prices
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's
FTC lawsuit claims drug middlemen are manipulating insulin market
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
Fierce Healthcare1d
FTC formally sues PBMs over insulin prices and warns manufacturers
“As the complaint explains, the PBMs have created and manage a system in which drug manufacturers compete for formulary ...
East Idaho News1h
New Idaho law to regulate pharmacy benefit managers. Will it reduce prescription drug costs?
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of tamping down prescription drug costs. The new law targets pharmacy benefit ...
Axios Vitals on MSN4d
Oregon lawmakers may target PBMs to regulate pharmacist pay
Some Oregon lawmakers say they plan to propose regulations on pharmacy benefit managers, following the lead of Congress and ...